Meritage Portfolio Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-173,562
Closed -$4.85M 334
2022
Q4
$4.85M Buy
173,562
+93,045
+116% +$2.38M 0.38% 88
2022
Q3
$1.88M Sell
80,517
-56,941
-41% -$1.72M 0.16% 171
2022
Q2
$4.64M Buy
+137,458
New +$4.81M 0.36% 93

Other funds holding OGN

Meritage Portfolio Management's OGN Position: Q1 2023 in Review

Meritage Portfolio Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 173,562 shares — an estimated $4.85M sold.

Meritage Portfolio Management first reported a position in OGN in Q2 2022 and held it in 3 quarters. The position peaked at $4.85M in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Meritage Portfolio Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Meritage Portfolio Management sold 173,562 Organon & Co shares in Q1 2023, an estimated $4.85M.
  • Meritage Portfolio Management first reported a position in Organon & Co in Q2 2022 and held it in 3 quarters.
  • Meritage Portfolio Management's Organon & Co position peaked at $4.85M in Q4 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Meritage Portfolio Management's 13F filing for Q1 2023, filed 25 Apr 2023.